Pain after amputation above knee Signs and Symptoms
Conditions
Interventions
Continuous peripheral infusion of local anesthetic ropivacaine for 72 hours through two catheters, placed in the sciathic nerve sheath and under the amputation wound. The randomisation was done with c
Sponsors
Helsinki University Hospital (Finland)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients presenting for above knee amputation for atherosclerosis obliterans willing to participate 2. Able to give informed consent 3. Able to assess pain using a verbal rating scale 4. Assesssed to be medically stable so that life expectancy exceeds 2 weeks as assessed by recruiting anesthesiologist
Exclusion criteria
Exclusion criteria: 1. Allergy to amide local anesthetics 2. Operating surgeon unable to insert the catheter as defined in the protocol 3. Planned epidural postoperative pain management
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain on the amputated limb 1-5 days after the operation assessed on VRS 0-4. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Pain on the amputated limb 1,3 and 12 months after the operation and amputation phantom limb pain 1-5 days after the operation and 1, 3 and 12 months after the operation on VRS 0-4 2. The consumption of opioid 1-5 days after the operation 3. Adverse events | — |
Countries
Finland
Outcome results
None listed